The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
BCL-2 family members and the mitochondria in apoptosis
Gross, A., McDonnell, J. M., & Korsmeyer, S. J. (1999) · Genes & Development · doi:10.1101/gad.13.15.1899 · Cited by 3,641
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
Self-citationp53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis
Earnshaw, W. C., Martins, L. M., & Kaufmann, S. H. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.383 · Cited by 2,760
Biochemical Pathways of Caspase Activation During Apoptosis
Budihardjo, I., Oliver, H., Lutter, M., Luo, X., & Wang, X. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.269 · Cited by 2,565
Structural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644
A Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523
Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., Sessa, W. C., & Walsh, K. (2000) · Nature Medicine · doi:10.1038/79510 · Cited by 1,439
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
Apoptosis control by death and decoy receptors
Ashkenazi, A., & Dixit, V. M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80034-9 · Cited by 1,288
Induction of Apoptosis by Cancer Chemotherapy
Kaufmann, S. H., & Earnshaw, W. C. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4838 · Cited by 1,266
Dimmeler, S., Aicher, A., Vasa, M., Mildner-Rihm, C., Adler, K., Tiemann, M., Rütten, H., Fichtlscherer, S., Martin, H., & Zeiher, A. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13152 · Cited by 1,211
Reed, J. C. (1998) · Oncogene · doi:10.1038/sj.onc.1202591 · Cited by 1,049
HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells
Llevadot, J., Murasawa, S., Kureishi, Y., Uchida, S., Masuda, H., Kawamoto, A., Walsh, K., Isner, J. M., & Asahara, T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13131 · Cited by 709
Raff, M. (1998) · Nature · doi:10.1038/24055 · Cited by 688
Lennernäs, H., & Fager, G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732050-00005 · Cited by 527
Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin.
Keyomarsi, K., Sandoval, L. S., Band, V., & Pardee, A. B. (1991) · PubMed · Cited by 459
McTaggart, F., Buckett, L., Davidson, R., Holdgate, G., McCormick, A., Schneck, D., Smith, G., & Warwick, M. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01454-0 · Cited by 413
Guijarro, C., Blanco-Colio, L. M., Ortego, M., Alonso, C., Ortiz, A., Plaza, J. J., Díaz, C., Hernández, G., & Egido, J. (1998) · Circulation Research · doi:10.1161/01.res.83.5.490 · Cited by 390
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.
Thibault, A., Samid, D., Tompkins, A. C., Figg, W. D., Cooper, M. R., Hohl, R. J., Trepel, J. B., Liang, B., Patronas, N., Venzon, D. J., et al. (1996) · PubMed · Cited by 362
Kawata, S., Yamasaki, E., Nagase, T., Inui, Y., Ito, N., Matsuda, Y., Inada, M., Tamura, S., Noda, S., Imai, Y., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1716 · Cited by 354
Rao, S., Porter, D. C., Chen, X., Herliczek, T., Lowe, M., & Keyomarsi, K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7797 · Cited by 345
Blais, L., Desgagné, A., & LeLorier, J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.15.2363 · Cited by 326
Istvan, E. S., Palnitkar, M., Buchanan, S. K., & Deisenhofer, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.5.819 · Cited by 324
Cell cycle-specific effects of lovastatin.
Jakóbisiak, M., Bruno, S., Skierski, J. S., & Darzynkiewicz, Z. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3628 · Cited by 295
A cell cycle-regulated inhibitor of cyclin-dependent kinases.
Hengst, L., Dulic, V, Slingerland, J. M., Lees, E., & Reed, S. I. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5291 · Cited by 287
HMG-CoA Reductase Inhibitors and Myotoxicity
Ucar, M., Mjorndal, T., & Dahlqvist, R. (2000) · Drug Safety · doi:10.2165/00002018-200022060-00003 · Cited by 279
Pharmacology of competitive inhibitors of HMg-CoA reductase
Corsini, A. (1995) · Pharmacological Research · doi:10.1016/1043-6618(95)80042-5 · Cited by 277
Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells.
Agarwal, B., Bhendwal, S., Halmos, B., Moss, S. F., Ramey, W. G., & Holt, P. R. (1999) · PubMed · Cited by 251
In Vivo Anti-Inflammatory Effect of Statins Is Mediated by Nonsterol Mevalonate Products
Diomede, L., Albani, D., Sottocorno, M., Donati, M. B., Bianchi, M., Fruscella, P., & Salmona, M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0801.094222 · Cited by 246
Dimitroulakos, J., Nohynek, D., Backway, K. L., Hedley, D. W., Yeger, H., Freedman, M. H., Minden, M. D., & Penn, L. Z. (1999) · Blood · doi:10.1182/blood.v93.4.1308 · Cited by 219
Self-citationXia, Z., Tan, M., Wei-Lynn Wong, W., Dimitroulakos, J., Minden, M., & Penn, L. (2001) · Leukemia · doi:10.1038/sj.leu.2402196 · Cited by 218
Self-citationApoptosis in cancer: cause and cure
Kaufmann, S. H., & Gores, G. J. (2000) · BioEssays · doi:10.1002/1521-1878(200011)22:11<1007::aid-bies7>3.0.co;2-4 · Cited by 214
Nègre-Aminou, P., van Vliet, A. K., van Erck, M., van Thiel, G. C. F., van Leeuwen, R. E. W., & Cohen, L. H. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(96)00184-1 · Cited by 212
Kusama, T., Mukai, M., Iwasaki, T., Tatsuta, M., Matsumoto, Y., Akedo, H., & Nakamura, H. (2001) · PubMed · Cited by 210
Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP.
Marcelli, M., Cunningham, G. R., Haidacher, S. J., Padayatty, S. J., Sturgis, L., Kagan, C., & Denner, L. A. (1998) · PubMed · Cited by 210
Recent advances in the study of prenylated proteins
Sinensky, M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00009-3 · Cited by 208
Cholesterol biosynthesis and metabolism
Russell, D. W. (1992) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00054556 · Cited by 200
Luskey, K. L., Faust, J. R., Chin, D. J., Brown, M. S., & Goldstein, J. L. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82087-0 · Cited by 196
Hunninghake, D. B. (1992) · Current Opinion in Lipidology · doi:10.1097/00041433-199202000-00005 · Cited by 195
Bernhard, E. J., McKenna, W. G., Hamilton, A. D., Sebti, S. M., Qian, Y., Wu, J., & Muschel, R. J. (1998) · PubMed · Cited by 195
HMG‐CoA reductase inhibitors and P‐glycoprotein modulation
Bogman, K., Peyer, A., Török, M., Küsters, E., & Drewe, J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703920 · Cited by 194
Current and future treatment of hyperlipidemia: the role of statins
Farnier, M., & Davignon, J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00423-8 · Cited by 193
Wu, X., Whitfield, L. R., & Stewart, B. H. (2000) · Pharmaceutical Research · doi:10.1023/a:1007525616017 · Cited by 189
Clinical Pharmacokinetics and Practical Applications of Simvastatin
Mauro, V. F. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324030-00002 · Cited by 188
Agarwal, B., Rao, C. V., Bhendwal, S., Ramey, W. R., Shirin, H., Reddy, B. S., & Holt, P. R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70342-2 · Cited by 185
Comparative Tolerability of the HMG-CoA Reductase Inhibitors
Farmer, J. A., & Torre-Amione, G. (2000) · Drug Safety · doi:10.2165/00002018-200023030-00003 · Cited by 181
Rao, S., Lowe, M., Herliczek, T. W., & Keyomarsi, K. (1998) · Oncogene · doi:10.1038/sj.onc.1202322 · Cited by 180
HMG-CoA Reductase Inhibitors (Statins) Characterized as Direct Inhibitors of P-Glycoprotein
Wang, E.-J., Casciano, C. N., Clement, R. P., & Johnson, W. W. (2001) · Pharmaceutical Research · doi:10.1023/a:1011036428972 · Cited by 176
Lovastatin Induces Growth Inhibition and Apoptosis in Human Malignant Glioma Cells
Jones, K. D., Couldwell, W. T., Hinton, D. R., Su, Y. H., He, S. K., Anker, L., & Law, R. E. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2861 · Cited by 176
Olson, R. E., & Rudney, H. (1983) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60431-8 · Cited by 165
Dimitroulakos, J., Ye, L. Y., Benzaquen, M., Moore, M. J., Kamel‐Reid, S., Freedman, M. H., Yeger, H., & Penn, L. Z. (2001) · PubMed · Cited by 164
Self-citationLee, S. J., Ha, M. J., Lee, J., Nguyen, P., Choi, Y. H., Pirnia, F., Kang, W.-K., Wang, X.-F., Kim, S.-J., & Trepel, J. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10618 · Cited by 160
Wong, B., Lumma, W. C., Smith, A. M., Sisko, J. T., Wright, S. D., & Cai, T. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.959 · Cited by 154
Dechend, R., Fiebeler, A., Park, J.-K., Müller, D. N., Theuer, J., Mervaala, E. M. A., Bieringer, M., Gulba, D. C., Dietz, R., Luft, F. C., et al. (2001) · Circulation · doi:10.1161/hc3001.092039 · Cited by 153
Gardner, R. G., & Hampton, R. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31671 · Cited by 149
Alonso, D. F., Fariña, H. G., Skilton, G., Gabri, M. R., Lorenzo, M. S. D., & Gomez, D. E. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006058409974 · Cited by 146
Isoprenoid-Mediated Inhibition of Mevalonate Synthesis: Potential Application to Cancer
Elson, C. E., Peffley, D. M., Hentosh, P., & Mo, H. (1999) · Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-87.x · Cited by 146
Cholesterol inhibition, cancer, and chemotherapy
Buchwald, H. (1992) · The Lancet · doi:10.1016/0140-6736(92)90744-n · Cited by 146
Inhibition of Isoprenoid Biosynthesis Induces Apoptosis in Human Promyelocytic HL-60 Cells
Pérez‐Sala, D., & Mollinedo, F. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1359 · Cited by 144
A Phase I-II Trial of Lovastatin for Anaplastic Astrocytoma and Glioblastoma Multiforme
Larner, J. M., Jane, J., Laws, E. R., Packer, R. J., Myers, C. E., & Shaffrey, M. E. (1998) · American Journal of Clinical Oncology · doi:10.1097/00000421-199812000-00010 · Cited by 142
Phase II Study of High-Dose Lovastatin in Patients with Advanced Gastric Adenocarcinoma
Kim, W. S., Kim, M. M., Choi, H. J., Yoon, S., Lee, M. H., Park, K., Park, C. H., & Kang, W. K. (2001) · Investigational New Drugs · doi:10.1023/a:1006481423298 · Cited by 137
Clinical Pharmacokinetics of Cerivastatin
ck, W. M. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039020-00002 · Cited by 135
Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view
Schimmer, A. D., Hedley, D. W., Penn, L. Z., & Minden, M. D. (2001) · Blood · doi:10.1182/blood.v98.13.3541 · Cited by 135
Self-citationFeleszko, W., Młynarczuk-Biały, I., Bałkowiec-Iskra, E., Czajka, A., Świtaj, T., Stokłosa, T., Giermasz, A., & Jakóbisiak, M. (2000) · PubMed · Cited by 134
Farnesyltransferase inhibitors: antineoplastic mechanism and clinical prospects
Prendergast, G. C. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00072-1 · Cited by 134
Masters, B. A., Palmoski, M. J., Flint, O. P., Gregg, R. E., Wang‐Iverson, D. B., & Durham, S. K. (1995) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1995.1058 · Cited by 132
Bouterfa, H., Sattelmeyer, V., Czub, S., Vordermark, D., Roosen, K., & Tonn, J. (2000) · PubMed · Cited by 131
Inhibition of cell growth by lovastatin is independent of ras function.
DeClue, J. E., Vass, W. C., Papageorge, A. G., Lowy, D. R., & Willumsen, B. M. (1991) · PubMed · Cited by 131
Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin
Wong, W. W.-L., Tan, M. M., Xia, Z., Dimitroualakos, J., Minden, M. D., & Penn, L. Z. (2001) · PubMed · doi:10.5167/uzh-58181 · Cited by 129
Self-citationKiener, P. A., Davis, P. M., Murray, J. L., Youssef, S., Rankin, B. M., & Kowala, M. C. (2001) · International Immunopharmacology · doi:10.1016/s0162-3109(00)00272-1 · Cited by 128
Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors
Moghadasian, M. H. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00199-x · Cited by 128
Maltese, W. A., Defendini, R., Green, R. A., Sheridan, K. M., & Donley, D. K. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112165 · Cited by 125
Bottorff, M. B., & Hansten, P. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.15.2273 · Cited by 124
Miller, A. C., Karikó, K., Myers, C. E., Clark, E. P., & Samid, D. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530222 · Cited by 123
Plosker, G. L., & Wagstaff, A. J. (1996) · Drugs · doi:10.2165/00003495-199651030-00011 · Cited by 123
Wächtershäuser, A., Akoglu, B., & Stein, J. M. (2001) · Carcinogenesis · doi:10.1093/carcin/22.7.1061 · Cited by 123
Safety Profiles for the HMG-CoA Reductase Inhibitors: Treatment and Trust
Davidson, M. H. (2001) · Drugs · doi:10.2165/00003495-200161020-00005 · Cited by 121
Prasanna, P., Thibault, A., Liu, L., & Samid, D. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66020710.x · Cited by 114
Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor
Bischoff, H., Angerbauer, R., Bender, J., Bischoff, E., Faggiotto, A., Petzinna, D., Pfitzner, J., Porter, M. C., Schmidt, D. D., & Thomas, G. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00188-3 · Cited by 110
Inhibition of pancreatic adenocarcinoma cell growth by lovastatin
Sumi, S., Beauchamp, R. D., Townsend, C. M., Uchida, T., Murakami, M., Rajaraman, S., Ishizuka, J., & Thompson, J. C. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90032-t · Cited by 107
Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line
Ghosh, P., Ghosh‐Choudhury, N., Moyer, M. L., Mott, G. E., Thomas, C. A., Foster, B. A., Greenberg, N. M., & Kreisberg, J. I. (1999) · Oncogene · doi:10.1038/sj.onc.1202792 · Cited by 107
Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy
POGSON, G. W., Kindred, L. H., & Carper, B. G. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00034-x · Cited by 105
Vitols, S., Norgren, S., Juliusson, G., Tatidis, L., & Luthman, H. (1994) · Blood · doi:10.1182/blood.v84.8.2689.2689 · Cited by 105
Dimitroulakos, J., & Yeger, H. (1996) · Nature Medicine · doi:10.1038/nm0396-326 · Cited by 104
Self-citationSebti, S. M., Tkalcevic, G. T., & Jani, J. P. (1991) · Cancer Communications · doi:10.3727/095535491820873371 · Cited by 104
Plosker, G. L., & McTavish, D. (1995) · Drugs · doi:10.2165/00003495-199550020-00009 · Cited by 102
Lovastatin Induces Apoptosis in Malignant Mesothelioma Cells
Rubins, J. B., Greatens, T. M., Kratzke, R. A., Tan, A., Polunovsky, V. A., & Bitterman, P. B. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709020 · Cited by 102
Montero, M. T., Hernández, O., Suárez, Y., Matilla, J., Ferruelo, A. J., Martı́nez-Botas, J., Gómez-Coronado, D., & Lasunción, M. A. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00417-2 · Cited by 97
Lovastatin-induced Apoptosis of Human Medulloblastoma Cell Lines in vitro
Macaulay, R. J. B., Wang, W., Dimitroulakos, J., Becker, L. E., & Yeger, H. (1999) · Journal of Neuro-Oncology · doi:10.1023/a:1006164406202 · Cited by 87
Self-citationGray-Bablin, J., Rao, S., & Keyomarsi, K. (1997) · PubMed · Cited by 87
Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin
Hawk, M. A., Cesen, K. T., Siglin, J. C., Stoner, G. D., & Ruch, R. J. (1996) · Cancer Letters · doi:10.1016/s0304-3835(96)04465-5 · Cited by 87
NK-104: a novel synthetic HMG-CoA reductase inhibitor
Kajinami, K., Mabuchi, H., & Saito, Y. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.11.2653 · Cited by 85
Stark, W. W., Blaskovich, M. A., Johnson, B. A., Qian, Y., Vasudevan, A., Pitt, B. R., Hamilton, A. D., Sebti, S. M., & Davies, P. A. (1998) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1998.275.1.l55 · Cited by 85
Bennis, F., Favre, G., Gaillard, F. L., & Soula, G. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550421 · Cited by 81
Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death
Park, C., Lee, I., & Kang, W. K. (2001) · Carcinogenesis · doi:10.1093/carcin/22.10.1727 · Cited by 81
Pleiotropic effects of statins: do they matter?
Gotto, A. M., & Farmer, J. A. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200108000-00004 · Cited by 78
Newman, A., Clutterbuck, R. D., Powles, R., Catovsky, D., & Millar, J. L. (1997) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199709055590 · Cited by 77
Haria, M., & McTavish, D. (1997) · Drugs · doi:10.2165/00003495-199753020-00008 · Cited by 75
Narisawa, T., Fukaura, Y., Terada, K., et al. (1994) · Carcinogenesis · doi:10.1093/carcin/15.9.2045 · Cited by 74
HMG-CoA reductase inhibitors: role in normal and malignant cells
Larsson, O. (1996) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(96)00193-x · Cited by 74
Sterol‐independent regulation of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase in tumor cells
Hentosh, P., Yuh, S. H., Elson, C. E., & Peffley, D. M. (2001) · Molecular Carcinogenesis · doi:10.1002/mc.1074 · Cited by 73
Harwood, H., Alvarez, I. M., Noyes, W. D., et al. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41954-6 · Cited by 72
Soma, M. R., Pagliarini, P., Butti, G., Paoletti, R., Paoletti, P., & Fumagalli, R. (1992) · PubMed · Cited by 70
Kawata, S., Takaishi, K., Nagase, T., et al. (1990) · PubMed · Cited by 68
Variable activation of lovastatin by hydrolytic enzymes in human plasma and liver
Tang, B.-K., & KALOW, W. (1995) · European Journal of Clinical Pharmacology · doi:10.1007/bf00196860 · Cited by 63
Clutterbuck, R. D., Millar, B. C., Powles, R., et al. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00783.x · Cited by 63
Interaction of cytosine arabinoside and lovastatin in human leukemia cells
Holstein, S. A., & Hohl, R. J. (2001) · Leukemia Research · doi:10.1016/s0145-2126(00)00162-4 · Cited by 63
Atorvastatin: A hydroxymethylglutaryl-coenzyme A reductase inhibitor
Malinowski, J. M. (1998) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/55.21.2253 · Cited by 62
Wang, I.-K., Lin‐Shiau, S., & Lin, J. (2000) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2000.d01-16.x · Cited by 59
Müller, C., Bockhorn, A. G., Klusmeier, S., et al. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.3.717 · Cited by 58
Minden, M. D., Dimitroulakos, J., Nohynek, D., & Penn, L. Z. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109097663 · Cited by 57
Self-citationIllingworth, D. R., & Tobert, J. A. (2001) · Advances in protein chemistry · doi:10.1016/s0065-3233(01)56003-9 · Cited by 53
Insull, W., Isaacsohn, J. L., Kwiterovich, P. O., Ma, P., Brazg, R., Dujovne, C. A., Shan, M., Shugrue-Crowley, E., Ripa, S., Tota, R. R., et al. (2000) · Journal of International Medical Research · doi:10.1177/147323000002800201 · Cited by 52
Inhibitory effect of Lovastatin on spontaneous metastases derived from a rat lymphoma
Matar, P., Rozados, V. R., Binda, M. M., Roggero, E., Bonfil, R. D., & Scharovsky, O. G. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1026448026716 · Cited by 49
Lovastatin Inhibits Tumor Growth and Metastasis Development of a Rat Fibrosarcoma
Matar, P., Rozados, V. R., Roggero, E., et al. (1998) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.1998.13.387 · Cited by 48
Statins Inhibit Leukocyte Recruitment
Kwak, B. R., & Mach, F. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvb.21.8.1256 · Cited by 44
Kikuchi, T., Nagata, Y., & Abe, T. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005753523949 · Cited by 42
Addeo, R., Altucci, L., Battista, T., Bonapace, I. M., Cancemi, M., Cicatiello, L., Germano, D., Pacilio, C., Salzano, S., Bresciani, F., et al. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0494 · Cited by 41
Activation of the cholesterol pathway and Ras maturation in response to stress
Shack, S., Gorospe, M., Fawcett, T. W., Hudgins, W. R., & Holbrook, N. J. (1999) · Oncogene · doi:10.1038/sj.onc.1203002 · Cited by 39
Lovastatin and simvastatin are modulators of the proteasome
Wójcik, C., Bury, M., Stokłosa, T., Giermasz, A., Feleszko, W., Młynarczuk-Biały, I., Pleban, E., Basak, G. W., Ōmura, S., & Jakóbisiak, M. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(00)00044-3 · Cited by 38
Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin
Maksumova, L., Ohnishi, K., Muratkhodjaev, F., Zhang, W., Pan, L., Takeshita, A., & Ohno, R. (2000) · Leukemia · doi:10.1038/sj.leu.2401856 · Cited by 37
Pedersen, T. R. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01449-7 · Cited by 36
Relationships among dolichyl phosphate, glycoprotein synthesis, and cell culture growth
Kabakoff, B., Doyle, J. W., & Kandutsch, A. A. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90736-i · Cited by 35
Lovastatin 5-year safety and efficacy study. Lovastatin Study Groups I through IV
(1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.9.1079 · Cited by 33
Kim, J.-S., Pirnia, F., Choi, Y. H., Nguyen, P. M., Knepper, B., Tsokos, M., Schulte, T. W., Birrer, M. J., Blagosklonny, M. V., Schaefer, O., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1204008 · Cited by 31
Holmberg, M., Sandberg, C., Nygren, P., & Larsson, R. L. (1994) · Anti-Cancer Drugs · doi:10.1097/00001813-199410000-00012 · Cited by 29
Biosynthesis and characterization of (S)-and (R)-3-hydroxy-3-methylglutaryl coenzyme A
Bischoff, K. M., & Rodwell, V. W. (1992) · Biochemical Medicine and Metabolic Biology · doi:10.1016/0885-4505(92)90060-c · Cited by 28
Ravid, T., Avner, R., Polak‐Charcon, S., Faust, J. R., & Roitelman, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29341 · Cited by 26
Thompson, G. R., & Naoumova, R. P. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.11.2619 · Cited by 23
Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells.
Feleszko, W., & Jakóbisiak, M. (2000) · PubMed · Cited by 23
Mevalonate Prevents Lovastatin-Induced Apoptosis in Medulloblastoma Cell Lines
Wang, W., & Macaulay, R. J. B. (1999) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100000433 · Cited by 22
Alberts, A. W., MacDonald, J. S., Till, A. E., & Tobert, J. A. (1989) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.1989.tb00519.x · Cited by 20
Drug firm withdraws statin from the market
Weber, W. E. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05756-7 · Cited by 18
Hanefeld, M., Jp, D., Ose, L., Durrington, P. N., Farmer, M., & Schmage, N. (1999) · Journal of International Medical Research · doi:10.1177/030006059902700302 · Cited by 18
In vitro antitumor activity of cerivastatin, a novel and potent HMG‐CoA reductase inhibitor
Feleszko, W., Młynarczuk-Biały, I., & Nowis, D. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02736-3 · Cited by 14
Kawata, S., Kakimoto, H., Ishiguro, H., et al. (1992) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1992.tb02732.x · Cited by 13
CLINICAL RATIONALE FOR ROSUVASTATIN, A POTENT NEW HMG‐COA REDUCTASE INHIBITOR
Hanefeld, M. (2001) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2001.tb11071.x · Cited by 12
Cellular senescence and cancer
(1999) · doi:10.1002/(sici)1096-9896(199901)187:1
Cited by
Mutant p53: one name, many proteins
Freed-Pastor, W. A., & Prives, C. (2012) · Genes & Development · doi:10.1101/gad.190678.112 · Cited by 1,247
Statin use and reduced cancer-related mortality
Nielsen, S. F., Nordestgaard, B. G., & Bojesen, S. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201735 · Cited by 1,030
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway
Freed-Pastor, W. A., Mizuno, H., Zhao, X., Langerød, A., Moon, S.-H., Rodriguez-Barrueco, R., Barsotti, A., Chicas, A., Li, W., Polotskaia, A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.017 · Cited by 865
27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
Nelson, E. R., Wardell, S. E., Jasper, J. S., Park, S., Suchindran, S., Howe, M. K., Carver, N. J., Pillai, R. V., Sullivan, P. M., Sondhi, V., et al. (2013) · Science · doi:10.1126/science.1241908 · Cited by 839
Demierre, M.-F., Higgins, P. D. R., Gruber, S. B., Hawk, E., & Lippman, S. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1751 · Cited by 819
Metadata
- Authors
- Wong, W. W.-L., Dimitroulakos, J., Minden, M., & Penn, L.
- Venue
- Leukemia
- Published
- 2002-04-01
- Volume
- 16
- Issue
- 4
- Pages
- 508-519
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2079430799
- Cited by
- 578
- References
- 143
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.